Our Pricing

Constipation On Mounjaro Timeline: What Happens

Published on: June 03, 2026

Understanding the constipation on mounjaro timeline uk helps you prepare for one of the most common digestive side effects of tirzepatide treatment. At Cured Pharmacy, our UK clinical team has supported thousands of patients through their Mounjaro journey, and we've compiled this evidence-based timeline to help you know exactly what to expect each week.

Why Mounjaro Causes Constipation: The Science Behind It

Mounjaro (tirzepatide) causes constipation through its dual action on GIP and GLP-1 receptors, which significantly slow gastric emptying and intestinal motility [1]. This mechanism is precisely what makes tirzepatide effective for weight loss, but it also means your digestive system processes food more slowly than usual.

In the SURPASS clinical trial programme, gastrointestinal side effects including constipation affected approximately 24% of patients on the highest maintenance doses [1]. The slowed gut transit time means stools remain in the colon longer, allowing more water absorption and resulting in harder, more difficult-to-pass bowel movements.

Unlike temporary digestive upset, constipation on Mounjaro is a pharmacological effect directly related to how the medication works. Understanding this helps explain why the timeline follows predictable patterns as your body adjusts to each new dose escalation.

Week-By-Week Constipation Timeline on Mounjaro

The constipation timeline on Mounjaro typically follows your dose escalation schedule. Most UK patients start on 2.5mg weekly for four weeks before increasing to 5mg, then potentially to 7.5mg, 10mg, 12.5mg, or 15mg depending on clinical response and tolerability [2].

Weeks 1-4: Initial 2.5mg Dose

During your first month on the 2.5mg starter dose, constipation is relatively uncommon. Most patients experience mild nausea or reduced appetite, but bowel movements typically remain near baseline. If constipation does occur at this stage, it's usually mild and responds well to increased fluid intake. This lower starting dose allows your digestive system to gradually adapt to tirzepatide's effects on gut motility.

Constipation During Dose Escalation: What to Expect

Constipation risk increases significantly when you escalate from 2.5mg to 5mg and beyond. Clinical data shows that gastrointestinal side effects peak within the first week after each dose increase, then gradually improve over the following 2-3 weeks as your body adjusts [1][2].

At the 5mg dose (weeks 5-8), approximately 15-20% of patients report constipation. This typically manifests as reduced bowel movement frequency, harder stools, and increased straining. The effect is usually most pronounced in days 2-5 after your injection, then improves slightly before your next weekly dose.

Higher maintenance doses of 10mg, 12.5mg, and 15mg carry the greatest constipation risk. In SURPASS-3, patients on 15mg tirzepatide reported constipation rates of approximately 24%, compared to 10% on placebo [1]. However, with proactive management strategies, most patients successfully continue treatment without discontinuation.

Peak Constipation Period

The most challenging period for constipation typically occurs between weeks 9-16, when you're on therapeutic doses of 7.5mg to 10mg or higher. During this phase, your prescriber may recommend temporarily pausing dose escalation to allow your digestive system to adapt. This is a normal part of the titration process and doesn't indicate treatment failure.

How Long Does Mounjaro Constipation Last?

For most UK patients, constipation improves significantly after 8-12 weeks on a stable maintenance dose. Your gut gradually adapts to the slowed motility, and with consistent management strategies, bowel movements often return to a comfortable pattern [2].

However, some degree of reduced bowel frequency may persist throughout treatment. Many patients report moving from daily bowel movements to every 2-3 days, which is still within normal range and not considered true constipation unless accompanied by straining, hard stools, or discomfort.

If severe constipation persists beyond 12 weeks on a stable dose despite management strategies, your UK prescriber may consider dose reduction or alternative weight loss treatments. At Cured Pharmacy, our clinical team provides ongoing support to optimise your treatment plan based on your individual response.

Evidence-Based Strategies to Manage Constipation on Mounjaro

Proactive management is essential from week one. Increase your water intake to at least 2-3 litres daily, as adequate hydration helps maintain softer stools even with slowed gut transit. Dietary fibre from vegetables, fruits, and whole grains provides bulk that stimulates bowel movements naturally.

Physical activity significantly improves gut motility. Even a 20-30 minute daily walk can counteract some of tirzepatide's constipating effects. Regular movement stimulates intestinal contractions and helps maintain more predictable bowel patterns.

Over-the-counter options include bulk-forming laxatives like ispaghula husk (Fybogel), which are safe for long-term use. Osmotic laxatives such as macrogol (Movicol) or lactulose draw water into the bowel and are appropriate for persistent constipation. Stimulant laxatives like senna should be reserved for occasional use only, as regular use can worsen constipation over time.

When to Contact Your Prescriber

Seek medical advice if you experience no bowel movement for more than 5 days, severe abdominal pain or bloating, blood in stools, or vomiting. These symptoms may indicate complications requiring clinical assessment. Your UK prescriber can adjust your Mounjaro dose or recommend prescription-strength treatments if over-the-counter measures prove insufficient.

Alternative Weight Loss Treatments With Different Side Effect Profiles

If constipation significantly impacts your quality of life despite management strategies, alternative weight loss medications may be more suitable. Wegovy (semaglutide) is a single GLP-1 receptor agonist that typically causes less severe constipation than tirzepatide, though it still affects gut motility [3].

Saxenda (liraglutide) requires daily injections but offers more flexible dosing adjustments if digestive side effects become problematic. Orlistat works through a completely different mechanism—blocking fat absorption—and doesn't affect gut motility, though it carries its own gastrointestinal considerations.

At Cured Pharmacy, our UK prescribers assess your medical history, weight loss goals, and side effect tolerance to recommend the most appropriate treatment. All prescription weight loss medications require clinical assessment and ongoing monitoring, with prices starting from competitive rates across our range.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Rosenstock, J., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143–155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
3. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro is a prescription-only medicine in the UK and must be prescribed following an online consultation with our clinical team.